MedPath

NEO-POLY-DEX

Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension USP (Sterile)

Approved
Approval ID

bf900a90-9ece-4bbb-9a72-6f7e5c04e202

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 3, 2010

Manufacturers
FDA

Butler Animal Health Supply

DUNS: 017880659

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code11695-1403
Application NumberANDA064135
Product Classification
M
Marketing Category
C73584
G
Generic Name
Neomycin sulfate, Polymyxin B Sulfate and Dexamethasone
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateNovember 14, 2008
FDA Product Classification

INGREDIENTS (10)

DexamethasoneActive
Quantity: 1 mg in 1 mL
Code: 7S5I7G3JQL
Classification: ACTIB
Neomycin SulfateActive
Quantity: 3.5 mg in 1 mL
Code: 057Y626693
Classification: ACTIB
Polymyxin B SulfateActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIB
Hydrochloric AcidInactive
Code: QTT17582CB
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
POLYSORBATE 20Inactive
Code: 7T1F30V5YH
Classification: IACT
WaterInactive
Code: 059QF0KO0R
Classification: IACT
Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
Sodium ChlorideInactive
Code: 451W47IQ8X
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NEO-POLY-DEX - FDA Drug Approval Details